𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pathogenic mutations in Parkinson disease

✍ Scribed by Eng-King Tan; Lisa M. Skipper

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
334 KB
Volume
28
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

R1514Q substitution in Lrrk2 is not a pa
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation
✍ William C. Nichols; Diane K. Marek; Michael W. Pauciulo; Nathan Pankratz; Cheryl πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 66 KB

## Abstract Mutations in __LRRK2__ were first reported as causing Parkinson's disease (PD) in late 2004. Since then, approximately a dozen __LRRK2__ substitutions have been identified that are believed to be pathogenic mutations. The substitution of adenine for guanine at nucleotide 4541 (4541G>A)

Pathogenic role of glial cells in Parkin
Pathogenic role of glial cells in Parkinson's disease
✍ Peter Teismann; Kim Tieu; Oren Cohen; Dong-Kug Choi; Du Chu Wu; Daniel Marks; Mi πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Abstract An erratum for this article appears in the January, 2004 issue of __Movement__ Disorders (Mov Disord 2004;19:119). Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of the dopaminergic neurons in the substantia nigra pars compacta (SN

Clarification: Pathogenic role of glial
Clarification: Pathogenic role of glial cells in Parkinson's disease
✍ Serge Przedborski πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 26 KB

## Abstract The original article to which this Clarification refers was published in the February 2003 issue of __Movement__ Disorders (Teismann P, Tieu K, Cohen O, Choi DK, Wu dC, Marks D, Vila M, Jackson‐Lewis V, Przedborski S. Pathogenic role of glial cells in Parkinson's disease. Mov Disord 200